Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 241

1.

Comparison of hyperglycemia, hypertension, and hypercholesterolemia management in patients with type 2 diabetes.

Grant RW, Cagliero E, Murphy-Sheehy P, Singer DE, Nathan DM, Meigs JB.

Am J Med. 2002 Jun 1;112(8):603-9.

PMID:
12034408
[PubMed - indexed for MEDLINE]
2.

Cardiovascular risk factors and metabolic control in type 2 diabetic subjects attending outpatient clinics in Italy: the SFIDA (survey of risk factors in Italian diabetic subjects by AMD) study.

Comaschi M, Coscelli C, Cucinotta D, Malini P, Manzato E, Nicolucci A; SFIDA Study Group--Italian Association of Diabetologists (AMD).

Nutr Metab Cardiovasc Dis. 2005 Jun;15(3):204-11.

PMID:
15955469
[PubMed - indexed for MEDLINE]
3.

Lack of management of cardiovascular risk factors in type 2 diabetic patients.

Yun KE, Park MJ, Park HS.

Int J Clin Pract. 2007 Jan;61(1):39-44.

PMID:
17229179
[PubMed - indexed for MEDLINE]
4.

Clinical inertia in the management of Type 2 diabetes metabolic risk factors.

Grant RW, Cagliero E, Dubey AK, Gildesgame C, Chueh HC, Barry MJ, Singer DE, Nathan DM, Meigs JB.

Diabet Med. 2004 Feb;21(2):150-5.

PMID:
14984450
[PubMed - indexed for MEDLINE]
6.

Antidiabetic prescriptions and glycemic control in German patients with type 2 diabetes mellitus: a retrospective database study.

Yurgin N, Secnik K, Lage MJ.

Clin Ther. 2007 Feb;29(2):316-25.

PMID:
17472823
[PubMed - indexed for MEDLINE]
7.

Development and clinical outcomes of pharmacist-managed diabetes care clinics.

Morello CM, Zadvorny EB, Cording MA, Suemoto RT, Skog J, Harari A.

Am J Health Syst Pharm. 2006 Jul 15;63(14):1325-31.

PMID:
16809752
[PubMed - indexed for MEDLINE]
9.

Control of diabetes and cardiovascular risk factors in patients with type 2 diabetes: a nationwide French survey.

Charpentier G, Genès N, Vaur L, Amar J, Clerson P, Cambou JP, Guéret P; ESPOIR Diabetes Study Investigators.

Diabetes Metab. 2003 Apr;29(2 Pt 1):152-8.

PMID:
12746636
[PubMed - indexed for MEDLINE]
Free Article
10.

Metabolic effects of pioglitazone in combination with insulin in patients with type 2 diabetes mellitus whose disease is not adequately controlled with insulin therapy: results of a six-month, randomized, double-blind, prospective, multicenter, parallel-group study.

Mattoo V, Eckland D, Widel M, Duran S, Fajardo C, Strand J, Knight D, Grossman L, Oakley D, Tan M; H6E-MC-GLAT study group.

Clin Ther. 2005 May;27(5):554-67.

PMID:
15978304
[PubMed - indexed for MEDLINE]
11.

Prevalence and type of dyslipidaemia in a population at risk for cardiovascular death in Bulgaria.

Temelkova-Kurktschiev TS, Kurktschiev DP, Vladimirova-Kitova LG, Vaklinova I, Todorova BR.

Folia Med (Plovdiv). 2009 Apr-Jun;51(2):26-32.

PMID:
19670537
[PubMed - indexed for MEDLINE]
12.

Muraglitazar, a dual (alpha/gamma) PPAR activator: a randomized, double-blind, placebo-controlled, 24-week monotherapy trial in adult patients with type 2 diabetes.

Buse JB, Rubin CJ, Frederich R, Viraswami-Appanna K, Lin KC, Montoro R, Shockey G, Davidson JA.

Clin Ther. 2005 Aug;27(8):1181-95.

PMID:
16199244
[PubMed - indexed for MEDLINE]
13.

LDL-C goal attainment among patients newly diagnosed with coronary heart disease or diabetes in a commercial HMO.

Nag SS, Daniel GW, Bullano MF, Kamal-Bahl S, Sajjan SG, Hu H, Alexander C.

J Manag Care Pharm. 2007 Oct;13(8):652-63.

PMID:
17970603
[PubMed - indexed for MEDLINE]
Free Article
14.

Suboptimal control of glycemia, blood pressure, and LDL cholesterol in overweight adults with diabetes: the Look AHEAD Study.

Bertoni AG, Clark JM, Feeney P, Yanovski SZ, Bantle J, Montgomery B, Safford MM, Herman WH, Haffner S; Look AHEAD Research Group.

J Diabetes Complications. 2008 Jan-Feb;22(1):1-9. doi: 10.1016/j.jdiacomp.2006.10.003.

PMID:
18191071
[PubMed - indexed for MEDLINE]
15.

Renal and retinal microangiopathy after 15 years of follow-up study in a sample of Type 1 diabetes mellitus patients.

Romero P, Salvat M, Fernández J, Baget M, Martinez I.

J Diabetes Complications. 2007 Mar-Apr;21(2):93-100.

PMID:
17331857
[PubMed - indexed for MEDLINE]
16.

["Diabetes in Germany"(DIG) study. A prospective 4-year-follow-up study on the quality of treatment for type 2 diabetes in daily practice].

Ott P, Benke I, Stelzer J, Köhler C, Hanefeld M.

Dtsch Med Wochenschr. 2009 Feb;134(7):291-7. doi: 10.1055/s-0028-1123994. Epub 2009 Feb 5. German.

PMID:
19197810
[PubMed - indexed for MEDLINE]
17.

Attainment of goals from national guidelines among persons with type 2 diabetes: a cohort study in an academic family medicine setting.

Kirk JK, Huber KR, Clinch CR.

N C Med J. 2005 Nov-Dec;66(6):415-9.

PMID:
16438097
[PubMed - indexed for MEDLINE]
18.

The effect of rosiglitazone on serum lipoprotein(a) levels in Korean patients with type 2 diabetes mellitus.

Ko SH, Song KH, Ahn YB, Yoo SJ, Son HS, Yoon KH, Cha BY, Lee KW, Son HY, Kang SK.

Metabolism. 2003 Jun;52(6):731-4.

PMID:
12800099
[PubMed - indexed for MEDLINE]
19.

Control of cardiovascular risk factors in patients with diabetes and hypertension at urban academic medical centers.

McFarlane SI, Jacober SJ, Winer N, Kaur J, Castro JP, Wui MA, Gliwa A, Von Gizycki H, Sowers JR.

Diabetes Care. 2002 Apr;25(4):718-23.

PMID:
11919131
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk